Why Canopy Growth (TSX:WEED) Stock Fell 25% in August 2019

Why Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock remains a top pick for cannabis investors.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Shares of Canada’s leading pot stock Canopy Growth (TSX:WEED)(NYSE:CGC) fell 25% in August 2019. Canopy Growth has lost close to $4 billion in market value last month. So, what drove Canopy Growth stock lower?

Canopy’s first-quarter results

Canopy Growth announced its fiscal first quarter of fiscal 2020 (ended in June) results on August 14, 2019. It reported revenue of $90.5 million with adjusted earnings per share (or EPS) of -$0.30 in the first quarter. This was above analyst revenue estimates of $86 million and EPS estimate of -$0.37.

However, Canopy Growth stock fell 14.5% on August 15, as investors were unimpressed with the company’s unadjusted net loss amounting to a massive $1.28 billion. Canopy Growth attributed the loss to its expansion efforts as well as its acquisition of Acreage Holdings.

Earlier this year, Canopy Growth agreed to acquire Acreage for $3.4 billion. Acreage Holdings is a U.S-based vertically integrated cannabis company. Investors were also worried about less than impressive sales in Canopy’s oils and gels business segment, driving its stock lower.

Constellation Brands books huge loss

Canopy Growth stock fell 6% on August 27 after its largest investor, Constellation Brands (NYSE:STZ) expects to book a loss of $54.8 million in the second quarter of fiscal 2020 (ended in August).

Constellation has attributed this loss to its investment in Canopy Growth. The total loss in the six months is expected to be $132 million for Constellation.

Constellation Brands had initially invested $190 million in Canopy Growth back in 2017 for a 10% stake. It has since increased its investments to $4 billion and now holds over 35% in Canopy Growth.

The last month saw several Cannabis stocks lose value. Aurora Cannabis was down 12%, while CannTrust,  and Hexo lost 26% and 6% respectively. The Horizons Marijuana Life Sciences Index ETF fell 13% in August 2019.

What next for Canopy Growth?

Canopy Growth investors have had a few rough months heading into September. The stock has fallen by a significant 54% since April 29, 2019. In July of this year, Canopy Growth’s board of directors ousted its founder and CEO Bruce Linton due to its piling losses.

While Canopy Growth is still booking massive losses, its management expects the firm to reach profitability within the next three to five years. It will continue to grow revenue at a considerable pace.

The total available market is estimated to expand robustly over the next few years and Canopy wants to focus on laying a strong foundation to benefit from this growth.

Canopy Growth wants to develop intellectual property, build brand value, expand to international markets and scale efficiently to grow sales as well as the bottom line.

During the earnings call, company CEO Mark Zekulin stated, “We are fixated on the process of evolving from builders to operators over the remainder of this fiscal year, meaning that as our expansion program comes to a close in Canada, and as new value-add products come to market in Canada, we demonstrate a sustainable, high margin, profitable Canadian business.”

Canopy Growth stock is one of the largest players in the cannabis space. It is trading at an attractive price after the recent pullback. Analysts also remain optimistic about Canopy and have a 12-month average target price of $56.67 which is 80% higher than the current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »